Healthcare providers may prescribe levodopa, dopamine agonists, anticholinergics, catechol-o-methyltransferase (COMT) inhibitors, and type-B monoamine oxidase (MAO-B) inhibitors to manage symptoms.

MAO A and MAO B, are involved in breaking down neurotransmitters, such as serotonin, norepinephrine, and dopamine. Higher- or lower-than-normal levels of these isoenzymes result in abnormal levels ...

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately 1,210 thousand in the US in 2023 which is expected to increase during the ...